Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma ; volume:23 ; number:1 ; day:3 ; month:11 ; year:2023 ; pages:1-9 ; date:12.2023
BMC cancer ; 23, Heft 1 (3.11.2023), 1-9, 12.2023
- Creator
-
Drouyer, Aurélien
Beaussire, Ludivine
Jorda, Pauline
Leheurteur, Marianne
Guillemet, Cécile
Berghian, Anca
Georgescu, Dragos
Di Fiore, Frédéric
Perdrix, Anne
Clatot, Florian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-11559-x
- URN
-
urn:nbn:de:101:1-2024012212115172798280
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Drouyer, Aurélien
- Beaussire, Ludivine
- Jorda, Pauline
- Leheurteur, Marianne
- Guillemet, Cécile
- Berghian, Anca
- Georgescu, Dragos
- Di Fiore, Frédéric
- Perdrix, Anne
- Clatot, Florian
- SpringerLink (Online service)
Other Objects (12)
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy
Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance
Deep learning-enabled breast cancer endocrine response determination from H&E staining based on ESR1 signaling activity
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial
Ribavirin restores ESR1 gene expression and tamoxifen sensitivity in ESR1 negative breast cancer cell lines
ESR1-Amplifikationen in humanen gynäkologischen Tumoren
Clinical relevance of circulating midkine in ulcerative colitis
Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients
Human endometrial cell coculture reduces the endocrine disruptor toxicity on mouse embryo development
Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance
Associations between Genetically Predicted Circulating Protein Concentrations and Endometrial Cancer Risk
ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy
Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance
Deep learning-enabled breast cancer endocrine response determination from H&E staining based on ESR1 signaling activity
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial
Ribavirin restores ESR1 gene expression and tamoxifen sensitivity in ESR1 negative breast cancer cell lines
ESR1-Amplifikationen in humanen gynäkologischen Tumoren
Clinical relevance of circulating midkine in ulcerative colitis
Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients
Human endometrial cell coculture reduces the endocrine disruptor toxicity on mouse embryo development
Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance
Associations between Genetically Predicted Circulating Protein Concentrations and Endometrial Cancer Risk
ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy
Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance
Deep learning-enabled breast cancer endocrine response determination from H&E staining based on ESR1 signaling activity
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial
Ribavirin restores ESR1 gene expression and tamoxifen sensitivity in ESR1 negative breast cancer cell lines
ESR1-Amplifikationen in humanen gynäkologischen Tumoren
Clinical relevance of circulating midkine in ulcerative colitis
Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients
Human endometrial cell coculture reduces the endocrine disruptor toxicity on mouse embryo development
Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance
Associations between Genetically Predicted Circulating Protein Concentrations and Endometrial Cancer Risk